Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

USA - NASDAQ:LILAK - BMG9001E1286 - Common Stock

8.08 USD
-0.2 (-2.42%)
Last: 9/19/2025, 8:26:16 PM
8.08 USD
0 (0%)
After Hours: 9/19/2025, 8:26:16 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LILAK. LILAK was compared to 35 industry peers in the Diversified Telecommunication Services industry. LILAK has a medium profitability rating, but doesn't score so well on its financial health evaluation. LILAK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year LILAK has reported negative net income.
LILAK had a positive operating cash flow in the past year.
In the past 5 years LILAK always reported negative net income.
LILAK had a positive operating cash flow in each of the past 5 years.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

With a Return On Assets value of -9.82%, LILAK is not doing good in the industry: 91.43% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -192.88%, LILAK is doing worse than 85.71% of the companies in the same industry.
LILAK has a better Return On Invested Capital (4.98%) than 65.71% of its industry peers.
LILAK had an Average Return On Invested Capital over the past 3 years of 4.30%. This is below the industry average of 6.32%.
The 3 year average ROIC (4.30%) for LILAK is below the current ROIC(4.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROIC 4.98%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

LILAK's Operating Margin of 14.37% is fine compared to the rest of the industry. LILAK outperforms 62.86% of its industry peers.
LILAK's Operating Margin has declined in the last couple of years.
The Gross Margin of LILAK (78.03%) is better than 94.29% of its industry peers.
In the last couple of years the Gross Margin of LILAK has remained more or less at the same level.
Industry RankSector Rank
OM 14.37%
PM (TTM) N/A
GM 78.03%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

LILAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LILAK has been reduced compared to 1 year ago.
The number of shares outstanding for LILAK has been increased compared to 5 years ago.
The debt/assets ratio for LILAK is higher compared to a year ago.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

LILAK has an Altman-Z score of 0.16. This is a bad value and indicates that LILAK is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.16, LILAK is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
The Debt to FCF ratio of LILAK is 37.83, which is on the high side as it means it would take LILAK, 37.83 years of fcf income to pay off all of its debts.
LILAK has a Debt to FCF ratio of 37.83. This is in the lower half of the industry: LILAK underperforms 60.00% of its industry peers.
A Debt/Equity ratio of 12.50 is on the high side and indicates that LILAK has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 12.50, LILAK is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Altman-Z 0.16
ROIC/WACC0.69
WACC7.18%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

LILAK has a Current Ratio of 1.08. This is a normal value and indicates that LILAK is financially healthy and should not expect problems in meeting its short term obligations.
LILAK has a Current ratio (1.08) which is comparable to the rest of the industry.
A Quick Ratio of 1.08 indicates that LILAK should not have too much problems paying its short term obligations.
LILAK has a Quick ratio (1.08) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

LILAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1346.34%.
The Revenue has decreased by -2.15% in the past year.
Measured over the past years, LILAK shows a small growth in Revenue. The Revenue has been growing by 2.88% on average per year.
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%

3.2 Future

The Earnings Per Share is expected to grow by 27.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, LILAK will show a small growth in Revenue. The Revenue will grow by 2.60% on average per year.
EPS Next Y82.44%
EPS Next 2Y44.84%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue Next Year-1.01%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.12%
Revenue Next 5Y2.6%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 24.75, LILAK is valued on the expensive side.
LILAK's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.86. LILAK is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 24.75
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LILAK indicates a somewhat cheap valuation: LILAK is cheaper than 80.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LILAK is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.5
EV/EBITDA 5.92
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LILAK's earnings are expected to grow with 30.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.84%
EPS Next 3Y30.42%

0

5. Dividend

5.1 Amount

No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (9/19/2025, 8:26:16 PM)

After market: 8.08 0 (0%)

8.08

-0.2 (-2.42%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners65.42%
Inst Owner Change-0.63%
Ins Owners11.61%
Ins Owner ChangeN/A
Market Cap1.62B
Analysts76
Price Target8.88 (9.9%)
Short Float %13.86%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2677.51%
Min EPS beat(2)-4518.74%
Max EPS beat(2)-836.29%
EPS beat(4)0
Avg EPS beat(4)-4375.62%
Min EPS beat(4)-10589%
Max EPS beat(4)-836.29%
EPS beat(8)2
Avg EPS beat(8)-5900.02%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.76%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-3.49%
Revenue beat(4)0
Avg Revenue beat(4)-3.47%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.18%
Revenue beat(12)0
Avg Revenue beat(12)-3.31%
Revenue beat(16)1
Avg Revenue beat(16)-2.55%
PT rev (1m)12.98%
PT rev (3m)12.93%
EPS NQ rev (1m)-129.54%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.99%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.75
P/S 0.37
P/FCF 7.5
P/OCF 2.18
P/B 2.66
P/tB N/A
EV/EBITDA 5.92
EPS(TTM)-5.93
EYN/A
EPS(NY)0.33
Fwd EY4.04%
FCF(TTM)1.08
FCFY13.34%
OCF(TTM)3.71
OCFY45.89%
SpS22.04
BVpS3.04
TBVpS-20.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROCE 6.3%
ROIC 4.98%
ROICexc 5.25%
ROICexgc 10.26%
OM 14.37%
PM (TTM) N/A
GM 78.03%
FCFM 4.89%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexcg growth 3Y-0.27%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Debt/EBITDA 4.86
Cap/Depr 56.57%
Cap/Sales 11.93%
Interest Coverage 1.06
Cash Conversion 47.45%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.16
F-Score4
WACC7.18%
ROIC/WACC0.69
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
EPS Next Y82.44%
EPS Next 2Y44.84%
EPS Next 3Y30.42%
EPS Next 5Y27%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%
Revenue Next Year-1.01%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.12%
Revenue Next 5Y2.6%
EBIT growth 1Y20.02%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year876.12%
EBIT Next 3Y118.64%
EBIT Next 5Y85.12%
FCF growth 1Y9.83%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-8.37%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%